Home Medical Devices Global Intramedullary Nail Market Size, Industry Share, Report to 2032

Intramedullary Nail Market

Intramedullary Nail Market Size, Share & Trends Analysis Report By Type (Titanium Alloys, Stainless Steel), By End-User (Hospitals, Specialty Orthopaedic and Trauma Centres, Others), By Sales Channels (Direct, Distribution Sales) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRMD872DR
Study Period 2020-2032 CAGR 6.53%
Historical Period 2020-2022 Forecast Period 2024-2032
Base Year 2023 Base Year Market Size USD 678.13 million
Forecast Year 2032 Forecast Year Market Size USD 1,198.23 million
Largest Market North America Fastest Growing Market Asia Pacific
The sample report only takes 30 secs to download, no need to wait longer.

Market Overview

The global intramedullary nail market size was valued at USD 678.13 million in 2023. It is expected to reach USD 1,198.23 million by 2032, growing at a CAGR of 6.53% during the forecast period (2024-32). The global market for intramedullary nails is expanding due to improvements in orthopedic surgical methods and materials, an aging population, and an increase in fractures caused by trauma and other lifestyle-related injuries. The global popularity of these implants in orthopedic treatments is fueled by their reduced post-operative complications and faster recovery times.

Market Overview

An intramedullary nail, sometimes referred to as an intramedullary rod, Kuntscher nail, or inter-locking nail, is a type of metal rod that is surgically inserted into the bone's medullary cavity to help stabilize and fixate fractures in the long bones. These types of orthopedic implants are commonly used to treat various injuries that may result from accidents, age-related bone degeneration, or conditions that cause low bone density. The market for these products encompasses a wide range of orthopedic issues and injuries. It plays a crucial role in helping patients recover and regain their mobility after bone fractures.


  • Titanium metal implants dominate the type segment
  • Hospital dominates the end-user segment
  • North America is the highest shareholder in the global market

Market Dynamics

Global Intramedullary Nail Market Drivers

Increasing Frequency of Road Accidents

An unprecedented spike in the frequency of road accidents has stimulated the market growth. As reported by the WHO, in 2023, approximately 1.19 million people meet fatal road traffic crashes and accidents annually. Similarly, an estimated 25 to 50 million other persons sustain non-fatal injuries that leave them severely disabled. Hence, these statistics suggest that the growing number of road injuries and accidents that lead to femoral neck or intertrochanteric bone fracture fuels the demand for intramedullary nails in healthcare facilities.

Moreover, as per the American Association for the Surgery of Trauma, injury accounts for over 3 million non-fatal injuries per year, amongst which 50,000 people die from trauma. Therefore, trauma patients require immediate medical treatment, such as implanting trauma-fixing devices, to heal. This is expected to drive market growth.

Increasing Demand for Minimally Invasive Surgeries

Patients' preference for less invasive intramedullary nail fixation—involving fewer incisions—is growing. As a result, significant players in the medical field are stepping up their efforts to develop methods related to this strategy. For instance, an intramedullary fixation using a fibular nail is a less invasive option than traditional plate fixation, offering better biomechanical strength and permitting immediate full weight-bearing after surgery.

These developments are intended to maintain safety and efficacy standards while reducing invasiveness and increasing efficiency. This strategy focus results from a deliberate attempt to address patient requests for less invasive orthopedic operations. It also drives innovation in minimally invasive intramedullary nailing, which improves patient outcomes worldwide and aligns with changing healthcare preferences.

Global Intramedullary Nail Market Restraint

High Cost of Implants

Intramedullary nails are expensive, which presents a major obstacle to their use in medical treatments. For many patients, these implants can be too costly despite their effectiveness, which limits their access to potentially life-saving procedures. The impact of this technology on traditional practice is felt by healthcare providers and facilities, leading to longer recovery periods and worse patient outcomes. Ensuring fair access to orthopedic therapies and enhancing the overall quality of healthcare delivery in communities across the globe depend on addressing the price of intramedullary nails. Such factors can hinder market growth.

Global Intramedullary Nail Market Opportunities

New Product Launch by Major Market Players

In the near future, organic growth strategies—especially product releases by major players in the market—are expected to drive market expansion. For example, the Gamma4 System, which is the next generation of Stryker's intramedullary nailing system, was introduced in September 2022 by a well-known medical equipment manufacturer. In order to treat conditions like osteoporotic and osteopenic bone density, this sophisticated system is carefully designed to address stable and unstable fractures, bone stabilization, and correction of bone deformities across various regions of the femur, including intracapsular, trochanteric, subtrochanteric, and shaft areas. These developments have the potential to increase market expansion and improve treatment efficacy.

Regional Analysis

Based on region, the global intramedullary nail market is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North America Dominates the Global Market

North America is the most significant global intramedullary nails market shareholder and is expected to expand substantially over the forecast period. Several key factors fuel the dominance of the intramedullary nail market. The market is expected to develop due to a sizable senior population with bone problems, rising regulatory approvals for medical devices, and an increasing need for enhanced clinical testing devices. Statistics from the Bone and Joints Burden Organization reveal the widespread impact of musculoskeletal disorders, with approximately 1 in 2 adults over 18 and 3 in 4 individuals over 65 affected. Similarly, road accidents result in 2.35 million injuries and over 37,000 fatalities annually, according to the Association for Safe International Road Travel (ASIRT). In comparison, 2.9 million sports injuries occur annually, as the American Physical Therapy Association reported.

Furthermore, the region benefits from high demand for specialized healthcare facilities, well-developed infrastructure, and extensive reimbursement coverage. Companies that manufacture orthopedic trauma and reconstruction devices, like Globus Medical, Inc., have seen revenue growth due to an increase in FDA approvals. For instance, Globus Medical has received over 82 product approvals. Similarly, government and private sector collaborations within the region enhance awareness, with various societies like the American Association of Hip and Knee Surgeons and the American Association for Surgery of Trauma actively promoting advanced treatment options and technological innovations.

In the Asia-Pacific region, the growing geriatric population, particularly in countries like Japan, presents a significant market opportunity. Asia is home to over 500 million individuals aged 65 and above, projected to rise to 923 million by 2050, according to the Asian Development Bank and United Nations data. Further, the prevalence of conditions such as diabetes, obesity, osteoarthritis, and osteoporosis drives market growth.

Moreover, economic growth in countries like India and China supports healthcare infrastructure development and the expansion of medical device companies, trauma centers, and specialty orthopedic centers, further boosting regional market growth. Overall, increasing patient awareness, economic factors, and healthcare infrastructure development are anticipated to drive substantial growth in the Asia-Pacific intramedullary nail market.

Report Scope

Report Metric Details
By Type
  1. Titanium Alloys
  2. Stainless Steel
By End-User
  1. Hospitals
  2. Specialty Orthopaedic and Trauma Centres
  3. Others
By Sales Channels
  1. Direct
  2. Distribution Sales
Company Profiles Zimmer Biomet Stryker Smith & Nephew Orthofix Medical Inc TREU-Instrumente GmbH CarboFix Orthopaedics Ltd MIZUHO Corporation Medtronic KanghuiOrthopaedics Jiangsu Jinlu Group Medical Device Co., Ltd Naton Medical Group Suzhou Xinrong Best Medical Instrument Co. Ltd Dragonbio (Mindray Orthopaedics) Ortho Solutions UK Ltd Advanced Orthopaedic Solutions DePuy Synthes Companies (Johnson & Johnson)
Geographies Covered
North America U.S. Canada
Europe U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
APAC China Korea Japan India Australia Singapore Taiwan South East Asia Rest of Asia-Pacific
Middle East and Africa UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
LATAM Brazil Mexico Argentina Chile Colombia Rest of LATAM
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Segmental Analysis

The global intramedullary nail market is bifurcated into type, end-user, and sales channels.

Based on type, the global intramedullary nail market is segmented into titanium alloys and stainless steel.

The titanium metal implants segment dominates the highest market share. The titanium alloy commonly used for implants, Ti6Al4VELI (ASTM F-136), offers numerous advantages over conventional materials, driving significant growth in this segment. Titanium implants exhibit reduced stress shielding and fatigue failure, attributed to their high biocompatibility, strength, rigidity, and corrosion resistance. They also boast non-allergic, non-magnetic, and non-radio-opaque properties, adhering readily to bone without external covering.

Being biologically inert, titanium forms a protective titanium dioxide layer upon contact with air or water, ensuring stability within the body. These attributes are particularly influential in developed economies, where titanium implants are increasingly favored due to their cost-effectiveness and superior performance.

Based on end-users, the global intramedullary nail market is segmented into hospitals, specialty orthopedic and trauma centers, and others.

The hospital owns the largest market share. Numerous factors contribute to market domination in the intramedullary nail segment. Contributions include advantageous payment rules, rising use of minimally invasive procedures, and state-of-the-art facilities such as orthopedic surgical robots. Hospitals' expansion of their healthcare infrastructure also contributes to segmental growth. There has been a noticeable increase in orthopedic procedures, especially for trauma injuries and femur shaft fractures.

For example, there are about 250,000 proximal femur fractures annually in the United States alone. Over 5 million people die from trauma-related injuries worldwide each year, according to the American Association for the Surgery of Trauma. Segment dominance is further cemented by the growing use of smart intramedullary nails for various bone restorations, including long bone fractures such as femoral neck fractures and intertrochanteric bone fractures.

Based on sales channels, the global intramedullary nail market is segmented into direct and distribution sales.

The direct sales channel facilitates direct communication between manufacturers and healthcare providers in the global intramedullary nail market, including hospitals, clinics, and ambulatory surgery centers. Manufacturers build direct connections with end consumers through this channel, enabling more individualized service, customized product offers, and effective communication about product features, advantages, and upgrades.

Manufacturers can offer full support through direct sales channels, including technical help, education, and training, which builds provider loyalty and trust. Direct sales channels also make it easier for manufacturers to respond quickly to client requirements and preferences, which helps them gain a competitive edge and expand their market share.

Market Size By Type

Market Size By Type
  • Titanium Alloys
  • Stainless Steel
  • Recent Developments

    • March 2023- X-Bolt, a company that develops innovative orthopedic devices, announced that their solution for hip fractures, the Pro-X1 Trochanteric Nail, received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The Pro-X1 Trochanteric Nailing System is designed to fix fractures in the femur of adults with osteopenia or osteoporosis.
    • November 2022- Enovis Corporation, a medical technology company, launched its latest product, the DynaNail Helix, as an addition to the DynaNail family and Enovis’ suite of foot and ankle products. The DynaNail Helix is designed to achieve sustained dynamic compression for subtalar fusion with its innovative and anatomically friendly design while allowing for simple screw-like insertion.

    Top Key Players

    Intramedullary Nail Market Share of Key Players

    Intramedullary Nail Market Share of Key Players
    Zimmer Biomet Stryker Smith & Nephew Orthofix Medical Inc TREU-Instrumente GmbH CarboFix Orthopaedics Ltd MIZUHO Corporation Medtronic KanghuiOrthopaedics Jiangsu Jinlu Group Medical Device Co., Ltd Naton Medical Group Suzhou Xinrong Best Medical Instrument Co. Ltd Dragonbio (Mindray Orthopaedics) Ortho Solutions UK Ltd Advanced Orthopaedic Solutions DePuy Synthes Companies (Johnson & Johnson) Others

    Frequently Asked Questions (FAQs)

    How big is the intramedullary nail market?
    The global intramedullary nail market size was valued at USD 678.13 million in 2023. It is expected to reach USD 1,198.23 million by 2032, growing at a CAGR of 6.53% from 2024 to 2032.
    Hospital end user segment is the leading segment for the market during forecast period.
    Rising frequency of road accidents, increasing demand for minimally invasive surgeries are the major growth factors of the intramedullary nail market.
    North America region has the largest share of the intramedullary nail market.
    The key players in the global intramedullary nail market include Zimmer Biomet, Stryker, Smith & Nephew, Orthofix Medical Inc, MIZUHO Corporation, Medtronic, KanghuiOrthopaedics, Jiangsu Jinlu Group, Medical Device Co., Ltd, Naton Medical Group, Ortho Solutions UK Ltd.

    We are featured on :